Estradiol-stimulated growth of MCF-7 tumors implanted in athymic mice: a model to study the tumoristatic action of tamoxifen
- PMID: 3386259
- DOI: 10.1016/0022-4731(88)90113-6
Estradiol-stimulated growth of MCF-7 tumors implanted in athymic mice: a model to study the tumoristatic action of tamoxifen
Abstract
Ovariectomized athymic (nude) mice were inoculated (10(7) cells) with the breast cancer cell line, MCF-7, into the axillary mammary fat pads. Tumors did not grow unless animals were implanted with a 1.7 mg estradiol sustained (8-week)-release cholesterol pellet. Co-implantation with tamoxifen (5 mg, 4-week release) caused an inhibition of estradiol-stimulated growth but did not cause tumor growth when implanted alone. The metabolism of [3H]tamoxifen was determined in the athymic mouse bearing MCF-7 tumors. Metabolites in the liver, uterus and tumor were determined by TLC. The principal metabolite in each of the tissues was 4-hydroxytamoxifen (by comparison of Rfs with authentic standards). Studies with 4-hydroxytamoxifen and N-desmethyltamoxifen (the principal metabolites in patients) showed that each was effective in inhibiting estradiol-stimulated tumor growth. However, tumor growth could be reactivated by treatment with estradiol alone. In a separate experiment, tumor-implanted animals were treated with tamoxifen for 1, 2 and 6 months. Tamoxifen did not cause tumor growth. Nevertheless, tumor growth was reactivated by estradiol on each occasion. These studies confirm the tumoristatic actions of tamoxifen and strongly support the view that therapy must be given indefinitely to patients to control tumor recurrence. The athymic mouse model can be used in the future to determine the efficacy of novel antiestrogens and the development of antiestrogen drug resistance.
Similar articles
-
Immune-deficient animals to study "hormone-dependent" breast and endometrial cancer.J Steroid Biochem. 1989;34(1-6):169-76. doi: 10.1016/0022-4731(89)90079-4. J Steroid Biochem. 1989. PMID: 2626014
-
Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.Clin Cancer Res. 2000 May;6(5):2028-36. Clin Cancer Res. 2000. PMID: 10815929
-
Investigation of the mechanism of tamoxifen-stimulated breast tumor growth with nonisomerizable analogues of tamoxifen and metabolites.J Natl Cancer Inst. 1993 May 19;85(10):806-12. doi: 10.1093/jnci/85.10.806. J Natl Cancer Inst. 1993. PMID: 8487325
-
Preclinical studies with toremifene as an antitumor agent.Breast Cancer Res Treat. 1990 Aug;16 Suppl:S9-17. doi: 10.1007/BF01807139. Breast Cancer Res Treat. 1990. PMID: 2149286 Review.
-
Chemosuppression of breast cancer with long-term tamoxifen therapy.Prev Med. 1991 Jan;20(1):3-14. doi: 10.1016/0091-7435(91)90002-l. Prev Med. 1991. PMID: 2008427 Review.
Cited by
-
Inhibition of estrogen signaling activates the NRF2 pathway in breast cancer.Breast Cancer Res Treat. 2010 Nov;124(2):585-91. doi: 10.1007/s10549-010-1023-8. Epub 2010 Jul 10. Breast Cancer Res Treat. 2010. PMID: 20623181 Free PMC article.
-
What do we know and what don't we know about tamoxifen in the human uterus.Breast Cancer Res Treat. 1994;31(1):27-39. doi: 10.1007/BF00689674. Breast Cancer Res Treat. 1994. PMID: 7981454 Review.
-
A new triphenylethylene derivative, TAT-59; hormone receptors; insulin-like growth factor 1; and growth suppression of hormone-dependent MCF-7 tumors in athymic mice.Cancer Chemother Pharmacol. 1994;34(5):372-6. doi: 10.1007/BF00685560. Cancer Chemother Pharmacol. 1994. PMID: 8070003
-
Experimental treatment of oestrogen receptor (ER) positive breast cancer with tamoxifen and brivanib alaninate, a VEGFR-2/FGFR-1 kinase inhibitor: a potential clinical application of angiogenesis inhibitors.Eur J Cancer. 2010 Jun;46(9):1537-53. doi: 10.1016/j.ejca.2010.02.018. Epub 2010 Mar 18. Eur J Cancer. 2010. PMID: 20303261 Free PMC article.
-
The Impact of ESR1 Mutations on the Treatment of Metastatic Breast Cancer.Horm Cancer. 2018 Aug;9(4):215-228. doi: 10.1007/s12672-017-0306-5. Epub 2018 May 7. Horm Cancer. 2018. PMID: 29736566 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical